Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Department of Neurology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Department of Neurology, The Second People's Hospital of Huai'an, Huai'an, Jiangsu, China.
World Neurosurg. 2019 Jun;126:e888-e894. doi: 10.1016/j.wneu.2019.03.006. Epub 2019 Mar 11.
Efficacy of minimally invasive craniopuncture with the YL-1 puncture needle (hard-channel) and soft drainage tube (soft-channel) in treating hypertensive intracerebral hemorrhage (HICH).
A total of 150 patients with HICH were randomly assigned into 3 groups: conservative group (n = 50), hard-channel group (n = 50), and soft-channel group (n = 50). Computed tomography, National Institutes of Health Stroke Scale (NIHSS) and the levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), superoxide dismutase (SOD), and malondialdehyde (MDA) in serum and in drainage fluid were examined on days 2, 4, and 6 after operation.
Compared with the conservative group, the serum levels of IL-6, TNF-α, and MDA were decreased and SOD was increased (P < 0.05); volumes of hematoma and perihematomal edema as well as NIHSS were reduced (P < 0.05) in minimally invasive groups on days 7, 14, and 28 after operation. Compared with the hard-channel group, the serum levels of IL-6, TNF-α, MDA, and SOD showed the same trend as above in the soft-channel group. In the soft-channel group, MDA was reduced and SOD was increased in brain drainage fluid on days 2, 4, and 6 (P < 0.05); volumes of hematoma and perihematomal edema on days 14 and 28 were found to be reduced compared with the hard-channel group (P < 0.05). There was no significant difference of volumes of hematoma and perihematomal edema on day 7 between minimally invasive groups. NIHSS of the soft-channel group appeared to be significantly reduced on days 7, 14, and 28 after operation (P < 0.05).
Soft-channel minimally invasive craniopuncture is an ideal technique for treating HICH, with advantages of alleviating cerebral edema, reducing oxidative stress, and inhibiting inflammatory response.
探讨应用 YL-1 型颅锥(硬通道)与软引流管(软通道)微创穿刺治疗高血压性脑出血(HICH)的疗效。
将 150 例 HICH 患者随机分为 3 组:保守组(n=50)、硬通道组(n=50)和软通道组(n=50)。术后第 2、4、6 天分别行头颅 CT 检查,采用美国国立卫生研究院卒中量表(NIHSS)评分,检测血清及引流液中白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、超氧化物歧化酶(SOD)、丙二醛(MDA)水平。
与保守组比较,微创组术后第 7、14、28 天血肿体积、血肿周围水肿体积及 NIHSS 评分均降低(P<0.05),血清中 IL-6、TNF-α、MDA 水平降低,SOD 水平升高(P<0.05);与硬通道组比较,软通道组术后第 7、14、28 天血肿体积、血肿周围水肿体积及 NIHSS 评分均降低(P<0.05),血清中 IL-6、TNF-α、MDA 水平降低,SOD 水平升高(P<0.05);软通道组术后第 2、4、6 天引流液中 MDA 水平降低,SOD 水平升高(P<0.05),第 14、28 天血肿体积、血肿周围水肿体积均较硬通道组减小(P<0.05)。微创组间术后第 7 天血肿体积、血肿周围水肿体积差异无统计学意义。软通道组术后第 7、14、28 天 NIHSS 评分均低于硬通道组(P<0.05)。
软通道微创穿刺术是治疗 HICH 的理想方法,可减轻脑水肿、降低氧化应激、抑制炎症反应。